The effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists.

Background: Low-dose (0.5 mg/day) colchicine improves cardiovascular outcomes in patients with stable coronary disease. Around 10-15% of these patients simultaneously use anticoagulant therapy, including vitamin-K antagonists (VKAs).